Please ensure Javascript is enabled for purposes of website accessibility

Why Aphria Stock Sank in March

By George Budwell - Apr 7, 2020 at 9:22AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The cannabis specialist's stock tumbled with the broader markets last month. Should investors take advantage of this weakness?

What happened

Shares of Canadian pot giant Aphria (APHA) lost 16.8% of their value in March, according to data from S&P Global Market Intelligence. The cannabis company's stock fell largely as a result of the marketwide downturn caused by the novel coronavirus.

On the bright side, Aphria's shares actually lost less ground in March than several of its chief competitors, including Aurora Cannabis, Canopy Growth, and Tilray. Specifically, Aurora's shares dropped 32%, Canopy plunged 23%, and Tilray plummeted 52%. 

Top view of a marijuana plant.

Image source: Getty Images.

So what

Early on in the month, Aphria's shares were on the same dreadful trajectory as its closest cannabis peers. In fact, Aphria's stock was down by as much as 38% halfway through the month. The company's saving grace turned out to be a positive note from Bank of America analyst Christopher Carey.

On March 20, Carey upgraded his outlook on Aphria's stock, thanks to the company's healthy cash position and recent ability to steadily grow its market share. Following this upgrade, shares immediately bounced off of their intramonthly lows and ended on a positive note (up 36% over the last two weeks of March).  

Now what

Is Aphria's stock worth buying after this March swoon? It all depends on your tolerance for risk and investing timeline. The bad news is that the legal marijuana industry is still facing a number of hurricane-force headwinds, and these issues won't be resolved overnight.

But if you're on the hunt for a cannabis stock to buy and hold for a solid decade, Aphria should definitely be on your radar. The company is among the rare few that has been profitable in the past year, it has a stronger balance sheet than most of its peers, and it has a foothold in key international markets like Germany. Aphria's value proposition will take a few years to round into shape, but this small-cap cannabis stock could be a big winner for patient investors.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aphria Stock Quote

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.